Synthesis and biological activity of retinoic acid receptor-alpha specific amides.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 12372520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.

  2001cited by this paper
• Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.

  1997cited by this paper
• Specific antagonist of retinoid toxicity in mice.

  1996cited by this paper
• Identification of a retinoic acid receptor alpha subtype specific agonist.

  1996cited by this paper
• Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

  1995cited by this paper
• Role of retinoic acid receptor gamma in the Rhino mouse and rabbit irritation models of retinoid activity.

  1995cited by this paper
• Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.

  1995cited by this paper
• Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism.

  1993cited by this paper
• 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

  1992cited by this paper
• 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

  1992cited by this paper
• 6'-substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands.

  1991cited by this paper
• Retinoic acid receptor gene expression in human skin.

  1991cited by this paper
• A third human retinoic acid receptor, hRAR-gamma.

  1989cited by this paper
• Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

  1988cited by this paper
• Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity.

  1988cited by this paper
• A new retinoic acid receptor identified from a hepatocellular carcinoma

  1988cited by this paper
• A human retinoic acid receptor which belongs to the family of nuclear receptors

  1987cited by this paper
• Identification of a receptor for the morphogen retinoic acid

  1987cited by this paper

• From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha

  2026cites this paper
• Retinoic Acid Signaling & Metabolism in Heart Failure.

  2025cites this paper
• Prediction and demonstration of retinoic acid receptor agonist Ch55 as an anti-fibrotic agent in the dermis.

  2023cites this paper
• Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies

  2023cites this paper
• Constructing an MCF-7 breast cancer cell-based transient transfection assay for screening RARα (Ant)agonistic activities of emerging phenolic compounds.

  2022cites this paper
• Retinoids in haematology : a timely revival?

  2021cites this paper
• Design of synthetic retinoids.

  2020cites this paper
• Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review

  2020cites this paper
• Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.

  2019cites this paper
• Discovery of retinoic acid receptor agonists as proliferators of cardiac progenitor cells through a phenotypic screening approach

  2019cites this paper
• Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

  2019cites this paper
• The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia

  2019cites this paper
• RARG Gene Dysregulation in Acute Myeloid Leukemia

  2019cites this paper
• Protagonist or antagonist? The complex roles of retinoids in the regulation of hematopoietic stem cells and their specification from pluripotent stem cells.

  2018cites this paper
• Relative contribution of health-related behaviours and chronic diseases to the socioeconomic patterning of low-grade inflammation

  2017cites this paper
• Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

  2017cites this paper
• Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.

  2017cites this paper
• Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist

  2017cites this paper
• Potential role for all-trans retinoic acid in nonpromyelocytic acute myeloid leukemia.

  2016cites this paper
• The role of vitamin A and retinoic acid receptor signaling in post-natal maintenance of bone.

  2016cites this paper
• Screening Chemicals for Receptor‐Mediated Toxicological and Pharmacological Endpoints: Using Public Data to Build Screening Tools within a KNIME Workflow

  2015cites this paper
• Binding affinity and efficacy-based pharmacophore modeling studies of retinoic acid receptor alpha agonists and virtual screening for potential agonists from NCI

  2014cites this paper
• An in vitro model for the pro‐fibrotic effects of retinoids: mechanisms of action

  2013cites this paper
• Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies

  2013cites this paper
• ATRA and the specific RARα agonist, NRX195183, have opposing effects on the clonogenicity of pre-leukemic murine AML1-ETO bone marrow cells

  2013cites this paper
• Retinoid receptors and therapeutic applications of RAR/RXR modulators.

  2012cites this paper
• Inhibition of ectopic bone formation by a selective retinoic acid receptor α‐agonist: A new therapy for heterotopic ossification?

  2010cites this paper
• Design of selective nuclear receptor modulators: RAR and RXR as a case study

  2007cites this paper
• Granulocyte Colony-Stimulating Factor and an RARα Specific Agonist, VTP195183, Synergize to Enhance the Mobilization of Hematopoietic Progenitor Cells

  2007influential citation
• RAR and RXR modulation in cancer and metabolic disease

  2007cites this paper
• Agents under investigation for the treatment and prevention of neutropenia

  2007cites this paper
• International Union of Pharmacology. LX. Retinoic Acid Receptors

  2006cites this paper
• Retinoids as therapeutic agents: today and tomorrow.

  2005cites this paper
• Design and synthesis of cyclic urea compounds: a pharmacological study for retinoidal activity.

  2004cites this paper
• Identification of the molecular requirements for an RAR alpha-mediated cell cycle arrest during granulocytic differentiation.

  2004cites this paper